John Prufeta

John Prufeta is General Partner and CEO of Medical Excellence Capital, LLC, an early-stage Life Sciences venture capital company focused on Gene/Cell Therapy, Quantum Biology, and Regenerative Medicine. He is Co-founder and Director of ProJenX, a company that has developed an advanced treatment for ALS. In addition, Prufeta serves as Director of Nobias, Inc, a company focused on rare children’s diseases.

Mr. Prufeta is co-founder and Chair of The Medical Excellence Foundation, a 501 (c)(3) charitable organization that funds cutting-edge medical research in top research institutions across the United States. In 2007, he founded and currently serves as Non-Executive Chairman of Medical Excellence International (MEI), a global private health advisory firm with offices in New York, London, Miami, Dubai, and Freiburg. The company is a virtual “Family Office for Health Care” offering comprehensive, state of the science programs in preventative medicine, complex case management, and longevity using a network of 33 academic medical centers and over 1250 carefully selected physicians.

Mr. Prufeta is the former president and CEO of Medix Resources, a publicly-held (NYSE:MXR) health care technology company. His prior experience includes Managing Partner of Agilence Health Advisors and OnPoint Partners, consulting companies advising academic medical centers, managed care organizations, and health care technology firms. He has several charitable interests including serving on the Board of Directors of Business Executives for National Security; as a founding Board member and current Vice Chairman of Veterans Moving Forward, a 501(c)(3) charity serving disabled veterans; as a President’s Advisory Board Member of Cold Spring Harbor Laboratories; as Advisory Board Member of The Center for Biotechnology at StonyBrook University; and as inaugural Co-Chair of the Leadership Institute at The University of Mount St. Vincent. He is a graduate of St. John’s University and Harvard Business School.